Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers.

Oh, Ji Min; Rajendran, Ramya Lakshmi; Gangadaran, Prakash; Hong, Chae Moon; Jeong, Ju Hye; Lee, Jaetae; Ahn, Byeong-Cheol

Oh, Ji Min; Rajendran, Ramya Lakshmi; Gangadaran, Prakash; Hong, Chae Moon; Jeong, Ju Hye; Lee, Jaetae; Ahn, Byeong-Cheol.

Afiliación

Oh JM; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Rajendran RL; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Gangadaran P; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Hong CM; BK21 FOUR KNU Convergence Educational Program of Biomedical Sciences for Creative Future Talents, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Jeong JH; Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Korea.
Lee J; Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu 41944, Korea.
Ahn BC; Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu 41944, Korea.

Cancers (Basel) ; 14(7)2022 Mar 31.

Article en En | MEDLINE | ID: mdl-35406554

Palabras clave

GLI1; radioactive-iodine therapy; redifferentiation; sodium iodide symporter; thyroid cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google